Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Thymalfasin.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Thymalfasin.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Thymalfasin.
Advertisement
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Thymalfasin.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Thymalfasin.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Thymalfasin.
Advertisement
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Thymalfasin.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Thymalfasin.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Thymalfasin.
Advertisement
Digoxin
Digoxin may decrease the cardiotoxic activities of Thymalfasin.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Thymalfasin.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Thymalfasin.
Ouabain
Ouabain may decrease the cardiotoxic activities of Thymalfasin.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Thymalfasin.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Thymalfasin.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Thymalfasin.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Thymalfasin.
